Arcus Biosciences revises non-employee director compensation, effective June 14, 2022

Arcus Biosciences, Inc.

Annual cash retainer set at $45,000 per director; additional retainers for lead independent director ($5,000) and committee chairs/members.
Initial equity award with ~$625,000 grant date fair value, split 2/3 stock options and 1/3 RSUs, vesting over 3 years.
Annual equity award with ~$350,000 grant date fair value, same option/RSU split, vesting fully after 12 months or next annual meeting.
All equity vests fully upon a change in control; new directors do not receive an annual award in the same calendar year.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.